About Boehringer Ingelheim Ltd

Boehringer Ingelheim are a pharmaceutical manufacturer that researches, develops, manufactures and markets novel medications of high therapeutic value for humans and veterinary medicine.

Founded in 1885, the company today operates globally with 146 affiliates and more than 47,000 employees. Their key areas of interest are respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system.

Their ambition is to serve mankind by being the preferred partner and admired competitor by being number one in animal health and biopharmaceutical contract manufacturing. By 2025, Boehringer Ingelheim aspire to grow their sales to €25 billion, to remain independent and continue to create value through innovation.

Chief Executive Officer Sabine Nikolaus lunches in the restaurant most days and always joins other tables or warmly and frequently invites people to join her at lunch. She maintains an open door policy (literally) and encourages people in the new starter video to come and seek her out.